YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Vortioxetine-Induced Amenorrhea: a Case Report

No Thumbnail Available

Date

2022

Journal Title

Journal ISSN

Volume Title

Publisher

Lippincott Williams & Wilkins

Abstract

Background: Vortioxetine is a novel multimodal antidepressant for the treatment of major depressive disorders and is widely used in clinical practice. Vortioxetine has a safe profile. However, there are case reports of other adverse effects in the literature. In this article, a case of amenorrhea due to vortioxetine is presented. Case: The patient is 36 years old, married, female, and is an anesthesiologist. She applied to the psychiatric outpatient clinic with symptoms of major depression. Vortioxetine was initiated at 10 mg/d and then gradually increased to 20 mg/d. She had regular menstruation until now. However, she did not menstruate after taking vortioxetine. The patient used vortioxetine for 3months and never had a period. Pregnancy test and other tests to investigate organic etiology were normal. Twoweeks after discontinuation of vortioxetine, the patient had a menstrual period. Conclusions: Further research is needed on the relationship and possible mechanisms between vortioxetine and amenorrhea.

Description

Kurhan, Faruk/0000-0003-3718-0458; Isik, Mesut/0000-0003-1707-7402

Keywords

Vortioxetine, Amenorrhea, Adverse Effect

Turkish CoHE Thesis Center URL

WoS Q

Q4

Scopus Q

Q3

Source

Volume

45

Issue

1

Start Page

7

End Page

8